par Grasberger, Helmut;Van Sande, Jacqueline ;Mahameed, Ahmad Hag-Dahood;Tenenbaum-Rakover, Yardena;Refetoff, Samuel
Référence The Journal of clinical endocrinology and metabolism, 92, 7, page (2816-2820)
Publication Publié, 2007-07
Référence The Journal of clinical endocrinology and metabolism, 92, 7, page (2816-2820)
Publication Publié, 2007-07
Article révisé par les pairs
Résumé : | In the human thyroid gland, TSH activates both the cAMP and inositol phosphates (IP) signaling cascades via binding to the TSH receptor (TSHR). Biallelic TSHR loss-of-function mutations cause resistance to TSH, clinically characterized by hyperthyrotropinemia, and normal or reduced thyroid gland volume, thyroid hormone output, and iodine uptake. |